Dr Lal PathLabs Ltd hits a fresh 52-week high

During Wednesday’s trading session, the stock of Dr Lal PathLabs registered a new 52-week high. The stock jumped more than 16.82 per cent and touched a fresh 52-week high of Rs 2,329.80 on BSE.

Moreover, the stock has increased by 25.08 per cent in the last three sessions.

The stock of Dr Lal PathLabs has recovered by 86.09 per cent from its sharp decline in March 2020. It has given returns of 65.99 per cent in just one year.

On a YTD basis, the stock has gained by 49.19 per cent. According to BSE data, the stock traded at a P/E multiple of 85.37 and a price-to-book ratio of 16.36.

Dr Lal PathLabs is a provider of diagnostic and related healthcare tests & services in India. The company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological & radiological investigations.

The share price of the company closed at Rs 2,227.20, up by 11.68 per cent on BSE.